House Ethics Office Says New York Congressman May Have Violated Rules
An inquiry centered on actions by a New York Congressman who is a majority stockholder in a biotech company.
Source: NYT Health - Category: Consumer Health News Authors: KATIE THOMAS and SHEILA KAPLAN Tags: Drugs (Pharmaceuticals) United States Politics and Government Stocks and Bonds Multiple Sclerosis Insider Trading House of Representatives Innate Immunotherapeutics Ltd Price, Thomas E (1954- ) Source Type: news
More News: Biotechnology | Government | Health | Medical Ethics | Multiple Sclerosis | Politics | USA Health